What Is Neoadjuvant Therapy?

0

Neoadjuvant therapies are drug treatments breast cancer patients receive before surgery. These treatments can help shrink tumors and make breast surgery easier for the patient and surgeon, according to Harold Burstein, MD, PhD, a breast cancer specialist in the Susan F. Smith Center for Women’s Cancers at Dana-Farber.

Neoadjuvant therapy may include chemotherapy or anti-estrogen treatments such as tamoxifen. Neoadjuvant therapy is sometimes also called upfront, preoperative, or induction therapy.

Learn more about neoadjuvant therapy in the video below:

Click here to learn more about aromatase inhibitors and tamoxifen, two other drugs used to treat breast cancer.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dana-Farber #researchers have shown that clonal hematopoiesis of indeterminate potential (CHIP) - the presence of s… https://t.co/ZlmXSeyKfZ
Dana-Farber @danafarber
CRISPR, a powerful new tool for editing the #DNA instruction manual in animals and humans, is proving a boon to… https://t.co/pCzS3riHPS

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.